pharma · Ventilator-Associated Pneumonia · Carcinoma, Squamous Cell
Janssen Research &
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Janssen Research & clinical programs — 7 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Raritan, USA
- Founded
- 2001
- Employees
- 95
- Programs
- 7
- Drugs
- 4
- Patents
- 0
Janssen Research & projects
7 ClinicalTrials.gov programs sponsored by Janssen Research &.
Janssen Research & has 7 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Doripenem
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Ventilator-Associated Pneumonia
1 trial -
JNJ-90301900 (NBTXR3)
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Carcinoma, Squamous Cell
1 trial -
Placebo
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Schizoaffective Disorder
1 trial -
Placebo
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Erectile Dysfunction
1 trial -
Rivaroxaban
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Atrial Fibrillation
1 trial -
Rivaroxaban 2.5 mg
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Acute Coronary Syndrome
1 trial -
Trabectedin
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Ovarian Cancer
1 trial
Frequently asked questions
How many clinical projects does Janssen Research & have?
7 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.